Are hepatitis C virus antibodies involved in chronic liver diseases other than non-A, non-B hepatitis?
✍ Scribed by Luis Viola; Eduardo Pimentel; Pedro Morgante; José Luis Fernández; Albert Parés; Josep Marí Barrera; Joan Caballería; Guadalupe Ercilla; Miquel Bruguera; Llorencl Caballería; Ricardo Castillo; Joan Rodés
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 221 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
B-cell non-Hodgkin's lymphoma (B-NHL) is a well-documented complication of hepatitis C virus (HCV) infection. Marginal zone (mucosa-associated lymphoid tissue; MALT) lymphomas constitute a less common type of B-NHL. In this article, we report a case of liver MALT in a cirrhotic patient, incidentally
## Abstract Serum samples were taken from 57 patients with sporadic non‐A, ‐B, and ‐C (Non A, B, C) acute hepatitis at different times after onset of the disease and tested for the presence of the hepatitis E virus (HEV) RNA, IgM, and low avidity IgG antibodies. The viral antibodies were detected u
Serum samples from healthy and diseased children were studied for the presence of TTV DNA by nested PCR using primer sets generated from N-22 region and from the untranslated region (UTR) of the viral genome. N-22 positive TTV DNA was detectable in 33 (27%) of 122 healthy children, 47 (73.4%) of 64
## Abstract Chronic hepatitis C virus HCV infection progresses through liver fibrosis and cirrhosis to hepatocellular carcinoma HCC. It appears to be causally related to B‐cell non‐Hodgkin's lymphoma since regression after antiviral therapy has been described. Two cases are described of non‐Hodgkin